UNSPSC 51103001: Petroleum/piperonyl butoxide/pyrethrins

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AP300. This VA Drug Class (AP300) classifies this compound as belonging to the group PEDICULICIDES.

UNSPSC 51103001 Petroleum/piperonyl butoxide/pyrethrins is a Commodity code, but the recent state and local opportunities posted under it do not align with pesticide or petroleum products. Instead, the code shows activity in pharmaceuticals, naloxone, medical and first aid supplies, and over-the-counter products — a significant mismatch between the nominal code scope and what is actually being solicited. The opportunities reflect procurement by health departments, fire departments, and cooperative purchasing alliances seeking prescription medications, emergency medical supplies, and drug deactivation systems. Issuing bodies include county health departments (Seminole County, Florida), municipal fire services (City of Tampa), state health agencies (Texas Health and Human Services Commission), and multi-state cooperative purchasing vehicles (Minnesota Multistate Cooperative Purchasing Alliance serving state and local members across multiple states including Oregon).

Recent activity spans Florida, Texas, and the multi-state MMCAP network. Seminole County released IFB 60459723LAS in June 2026 to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county health building, response due July 26, 2023. The City of Tampa posted ITB 26P00145 in March 2026 seeking medical and first aid supplies (169 line items including respiratory equipment, cardiac monitoring electrodes, and consumables) for the Tampa Fire Department Rescue Division, with response due March 13, 2026, estimated contract value $700,000 and designated as a sheltered-market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. The Texas HHS Commission issued RFI HHS0017013 in April 2026 to gather vendor capabilities on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements. The Minnesota Multistate Cooperative Purchasing Alliance released RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and over-the-counter products through authorized wholesalers, with proposals due March 26, 2026, two-year contract term, and evaluation weighted 75 percent on price competitiveness. The code's pharmaceutical and medical focus suggests a data-taxonomy mismatch rather than active pesticide procurement.